Invitation to the Extraordinary General Assembly and Audit Committee Report for FY 2024
2025-05-08
Financial
Avalon Pharma is pleased to invite its shareholders to attend the Extraordinary General Assembly Meeting 2025, which will include key agenda items such as:
-
Review of the 2024 financial statements and Board report.
-
Appointment of external auditors and interim dividend authorization.
-
Approval of updates to the remuneration policy.
-
Voting on related-party transactions.
The meeting will also present the Audit and Compliance Committee Report, confirming the effectiveness of the internal control system and noting no material issues for the fiscal year 2024.
Avalon Pharma GA Agenda 25_ENG.pdf
Stay informed about the future of healthcare
Visit our newsroom today to stay up to date.
